AstraZeneca · 6 days ago
Global Study Manager, Cell Therapy
Gaithersburg, MD
Full-time
Onsite
Mid Level
$112K/yr - $168K/yr
3+ years expAstraZeneca is a pioneer in collaborative research, focusing on improving the lives of millions with cancer. As a Global Study Manager in Cell Therapy, you will support the delivery of clinical studies, ensuring quality and compliance while managing third-party vendors and overseeing study conduct and progress.
BiotechnologyMedical DeviceHealthcarePharmaceuticalBiopharmaHealth CareMedicalPrecision Medicine
Responsibilities
Contribute to the development of study documents
Lead the preparation of country-specific agreements
Manage third-party vendors
Provide input to data management documents
Ensure the supply of study materials
Oversee third-party vendors, global / local internal staff, and investigator sites to support effective delivery of a study
Monitor study conduct and progress
Support risk management and quality efforts
Assist in the implementation of audits and regulatory inspections
Qualification
Required
Bachelor's degree with 3+ years of experience
Experience of working with and delivering through strategic partners and 3rd party vendors
Excellent knowledge of ICH-GCP principles
Clinical Study Management experience
Team orientated
Ability to lead, coordinate and prioritize multiple tasks and deliverables
Proactive approach to achieving study goals
Demonstrated verbal and written communication skills
Good negotiation and collaboration skills
Demonstrated interpersonal and problem-solving skills
Ability to manage change with a high degree of flexibility
Some travel may be required
Preferred
Early phase oncology clinical trial experience
Experience in autologous or allogeneic therapies
Benefits
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
2026-02-12
2026-02-12
2026-02-12
Company data provided by crunchbase